Molecular Partners Ag (MOLN) Other financing activities (2020 - 2024)

Molecular Partners Ag (MOLN) has reported Other financing activities for 5 consecutive years, with $1154.2 the latest figure, recorded in Q3 2024.

• On a quarterly basis, Other financing activities fell 49.03% year-over-year to $1154.2 in Q3 2024; TTM through Sep 2024 was $43257.4, a 22.39% increase from a year earlier, with the FY2023 full-year figure at $34516.7, down 86.83% from the prior year.
• Other financing activities was $1154.2 for Q3 2024 at Molecular Partners Ag, down from $38702.8 in the prior quarter.
• Over five years, Other financing activities peaked at $244714.7 in Q1 2022 and troughed at $1145.7 in Q1 2024.
• A 5-year average of $40897.6 and a median of $10901.7 in 2022 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities jumped 342.5% in 2022 and slumped 99.12% in 2023, its largest moves.
• Over 5 years, Other financing activities stood at $96235.5 in 2020, then declined by 21.12% to $75915.1 in 2021, then slumped by 95.9% to $3114.1 in 2022, then slipped by 27.6% to $2254.7 in 2023, then slumped by 48.81% to $1154.2 in 2024.
• The last three Other financing activities figures came in at $1154.2 (Q3 2024), $38702.8 (Q2 2024), and $1145.7 (Q1 2024), per Business Quant data.